Immune evasion by Kaposi's sarcoma-associated herpesvirus. - Wikidata - awgldk - TriplyDB

Immune evasion by Kaposi's sarcoma-associated herpesvirus.

Immune evasion by Kaposi's sarcoma-associated herpesvirus.

http://www.wikidata.org/entity/Q34795543

about

A new insight into viral proteins as Immunomodulatory therapeutic agents: KSHV vOX2 a homolog of human CD200 as a potent anti-inflammatory protein Next-Generation Sequencing in the Understanding of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Biology Bilateral inhibition of HAUSP deubiquitinase by a viral interferon regulatory factor protein Interference with the Autophagic Process as a Viral Strategy to Escape from the Immune Control: Lesson from Gamma Herpesviruses Kaposi's sarcoma-associated herpesvirus K3 and K5 ubiquitin E3 ligases have stage-specific immune evasion roles during lytic replication Kaposi's sarcoma-associated herpesvirus ORF18 and ORF30 are essential for late gene expression during lytic replication.Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.Role of host microRNAs in Kaposi's sarcoma-associated herpesvirus pathogenesis.Illumination of murine gammaherpesvirus-68 cycle reveals a sexual transmission route from females to males in laboratory mice.Inhibition of RIG-I-mediated signaling by Kaposi's sarcoma-associated herpesvirus-encoded deubiquitinase ORF64.Cytokine homologs of human gammaherpesviruses.Modulation of Immune System by Kaposi's Sarcoma-Associated Herpesvirus: Lessons from Viral Evasion Strategies.Inhibition of Kaposi's sarcoma-associated herpesvirus lytic replication by HIV-1 Nef and cellular microRNA hsa-miR-1258.Evasion of adaptive and innate immune response mechanisms by γ-herpesviruses.Guanylate-Binding Protein 1 Inhibits Nuclear Delivery of Kaposi's Sarcoma-Associated Herpesvirus Virions by Disrupting Formation of Actin Filament.Major Histocompatibility Complex Class II HLA-DRα Is Downregulated by Kaposi's Sarcoma-Associated Herpesvirus-Encoded Lytic Transactivator RTA and MARCH8.Preparation and characterization of polyclonal antibody against Kaposi's sarcoma-associated herpesvirus lytic gene encoding RTA.Kaposi's sarcoma-associated herpesvirus-encoded LANA recruits topoisomerase IIβ for latent DNA replication of the terminal repeats.Kaposi's Sarcoma-Associated Herpesvirus Increases PD-L1 and Proinflammatory Cytokine Expression in Human Monocytes.The T antigen locus of Merkel cell polyomavirus downregulates human Toll-like receptor 9 expression.Deregulation of HDAC5 by Viral Interferon Regulatory Factor 3 Plays an Essential Role in Kaposi's Sarcoma-Associated Herpesvirus-Induced Lymphangiogenesis.Caspase-dependent suppression of type I interferon signaling promotes KSHV lytic replication.KSHV de-regulates host cellular replication during lytic reactivation by disrupting the MCM complex through ORF59 Importance of Promyelocytic Leukema Protein (PML) for Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication

P2860

Q26751623-F95BF77F-F60C-404C-AE52-0A5F5BC1378E Q26752599-63B276F0-C953-4824-97BB-5C7B691667B3 Q27675410-A0B0586A-3743-4219-A8E4-FE51E877EA75 Q28080898-DDA1D6D7-2D48-445F-A25B-7F64A400E0D1 Q34059252-B46E6C00-7D28-40BD-9685-E02676D6D60B Q34261905-BAC9F6BA-945B-46A3-8C95-3F749DA80F9D Q34541350-BB29376E-C973-4EA7-9AE7-8C8FCC1B6AD5 Q34580878-B5B6CE2A-C1C6-4C88-9E0E-7CFEAE267B96 Q34671906-504BCB6F-EBD1-4992-8783-82FA9AD298EB Q35275001-F59603B4-B492-43B4-BA83-6FE84A94EF89 Q35743839-6B125AC1-BBC6-4EC4-941B-242A468F1B6E Q35801076-FA224BBA-47C2-48A3-A3CF-EF5E660EF831 Q37714039-EF72D524-9CB8-4DB8-A5A8-AE2BBF7487A0 Q38111863-BCB650D2-1720-4CEE-B052-C5484E11BF43 Q38700921-802F8580-CA34-4637-A674-4741C2FFCDF3 Q38760916-7F8B7B69-58F1-4EF8-B38D-27593D6218C8 Q38892087-2BA65291-0F45-43E3-853C-B18C950FB667 Q39320195-6CEA11F7-779A-455E-95E7-44A42301F97D Q41919772-87A111A2-14F2-454B-AC60-567AE4BB8BC6 Q42266941-3C766047-95BB-4A69-94E6-95E8F1773FDF Q47552839-E70C6FF7-8FF1-4F82-B3D8-065E1E0A2621 Q50420476-77C4E2E5-2539-45CB-A495-A0CC1E45326E Q57753235-ab8d94cb-4b38-07fa-0881-7740ae718edf Q57817539-F338C311-7352-4235-B4A6-493010714321

P2860

Immune evasion by Kaposi's sarcoma-associated herpesvirus.

http://www.wikidata.org/entity/Q34795543

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Immune evasion by Kaposi's sarcoma-associated herpesvirus.

@ast

Immune evasion by Kaposi's sarcoma-associated herpesvirus.

@en

Immune evasion by Kaposi's sarcoma-associated herpesvirus.

@nl

type

label

Immune evasion by Kaposi's sarcoma-associated herpesvirus.

@ast

Immune evasion by Kaposi's sarcoma-associated herpesvirus.

@en

Immune evasion by Kaposi's sarcoma-associated herpesvirus.

@nl

prefLabel

Immune evasion by Kaposi's sarcoma-associated herpesvirus.

@ast

Immune evasion by Kaposi's sarcoma-associated herpesvirus.

@en

Immune evasion by Kaposi's sarcoma-associated herpesvirus.

@nl

P1433

Q34795543-4234AA84-EB10-4AC0-9FE0-206196FBE621

P1476

Q34795543-9A9DA927-C8E5-4D9C-B88D-F52FB4258C83

P2093

Q34795543-4B5BC2BA-6328-4133-A74D-D922AE7BCC2C

Q34795543-938895F0-4C1B-4474-8E47-EA9615099195

Q34795543-B520B275-AB10-4F9E-8560-89539DFBBBF1

Q34795543-B791A381-D604-42BA-9740-4B469689A021

Q34795543-BDD835C0-B1E5-42B8-8785-EE46884E0F4A

P2860

Q34795543-0032256E-96E0-43FD-AC38-DF202C3A695E

Q34795543-00D0F638-CF21-4188-853F-F691C6EF0FCC

Q34795543-014C5B5F-3912-43E2-AC33-76AD520AD9E9

Q34795543-01827136-D901-47DC-ABF6-234DECF69921

Q34795543-01CE2F93-6DD7-4F45-A1B7-0DF37EE1EDAB

Q34795543-08570587-4746-476B-A70F-2692F191406B

Q34795543-0BC8ACD5-C081-4925-B0DE-08BD8DC078A2

Q34795543-0CA9403C-3FE9-409A-9AB3-58736B60CC64

Q34795543-0CDDA2D6-B424-4981-BCC2-A5FB8F0CF8ED

Q34795543-0D8A06D7-C0D3-41E9-8B21-E80AF500FA9C

P304

Q34795543-CB91B448-340C-4B7E-9946-659640310211

P31

Q34795543-FAD4739F-D8A3-405E-A06F-E4AA02A39B14

P356

Q34795543-9761BDBD-EA56-4D35-8E17-1ECEE50E91C7

P433

Q34795543-A9A76337-B19B-4F1A-8B3F-75D58D77A95B

P478

Q34795543-ACA69384-C3D7-4D27-A009-B8C856841B31

P577

Q34795543-371BFB0B-4263-4184-8ED6-418DA9C2D85E

P5875

Q34795543-70282310-5358-459C-96B6-023959B6114E

P698

Q34795543-B9445422-75CA-445B-A865-E76D064655B2

P932

Q34795543-F3CA405D-44B5-4E02-8312-7CFD8591496D

P356

P1433

Future Microbiology

P1476

Immune evasion by Kaposi's sarcoma-associated herpesvirus.

@en

P2093

Hye-Ra Lee

http://www.w3.org/2001/XMLSchema#string

Jae U Jung

http://www.w3.org/2001/XMLSchema#string

Parkash Gill

http://www.w3.org/2001/XMLSchema#string

Preet M Chaudhary

http://www.w3.org/2001/XMLSchema#string

Stacy Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2

Agonists and inverse agonists for the herpesvirus 8-encoded constitutively active seven-transmembrane oncogene product, ORF-74

Functional role of type I and type II interferons in antiviral defense

Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinase.

A Kaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation.

T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1

Kaposi's sarcoma-associated herpesvirus vCyclin open reading frame contains an internal ribosome entry site

Antiviral actions of interferons

Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells

Human herpesvirus 8 K14 protein mimics CD200 in down-regulating macrophage activation through CD200 receptor

P304

1349-1365

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FMB.10.105

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46402529

http://www.w3.org/2001/XMLSchema#string

P698

20860481

http://www.w3.org/2001/XMLSchema#string

P932

3076960

http://www.w3.org/2001/XMLSchema#string